Navigation Links
3SBio Inc. To Present at the DB Access Asia Conference 2012
Date:5/27/2012

SHENYANG, China, May 27, 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that 3SBio will attend the DB Access Asia Conference 2012 in Singapore on May 29, 2012. A copy of 3SBio's investor presentation material for the Conference is available at www.3sbio.com/en/investors/conferences

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.


Investor Contacts

Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820
ir@3SBio.com

Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991
ir@3SBio.com



'/>"/>
SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
2. 3SBio Inc. to Present at the Oppenheimer & Co. 6th Annual China Dragon Conference
3. 3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2011 Results
4. 3SBio Inc. to Present at 30th Annual J.P. Morgan Healthcare Conference
5. 3SBio Inc. Schedules Unaudited Third Quarter 2011 Results
6. 3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011
7. 3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results
8. 3SBio Inc. Schedules Unaudited Second Quarter 2011 Results
9. 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
10. 3SBio Announces Conversion of Isotechnika Debenture
11. 3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... 2017  BDI Group subsidiary Pathway Purchasing Network, ... organization serving specialty pharmacies, home infusion companies and ... significant, value-added member programs designed to help organizations ... and improve access and affordability for patients who ... Pathway has worked ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
(Date:7/5/2017)... , July 5, 2017 Wolfmet 3D ... answer as physics and manufacturing combine to progress molecular radiotherapy ... existing SPECT systems are unable to accurately quantify the radiation ... limited information regarding the success of this radiotherapy treatment has ... ...
Breaking Medicine Technology:
(Date:7/23/2017)... Melbourne, Fla. (PRWEB) , ... July 23, 2017 ... ... Stern, M.D., has joined Florida Pain Relief Group – Melbourne, a practice owned ... to board certification in interventional pain management, Dr. Stern also is certified in ...
(Date:7/22/2017)... , ... July 22, 2017 , ... ... year with the majority of patients not requiring pain medication after three months ... Sports Medicine’s Annual Meeting today in Toronto, Ontario, Canada found that those ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Wettstein Agencies, a ... in the greater Denver region, is announcing a charity drive to help raise ... kind of epilepsy. , Until a few months ago, Dominik was a healthy ...
(Date:7/21/2017)... Saint Paul, Minnesota (PRWEB) , ... July 21, ... ... architectural designers BWBR recently were selected to renovate and improve the Ramsey County ... building immediately adjacent to Regions Hospital, the $2.5 million project is scheduled to ...
(Date:7/21/2017)... ... , ... Bernard R. Bach, Jr., MD, orthopaedic surgeon at Rush University Medical ... Sports Medicine (AOSSM) , received the 2017 Robert E. Leach Sports Medicine Leadership award ... prestigious award is given annually to honor those who have made a significant contribution ...
Breaking Medicine News(10 mins):